青黛散灌肠治疗溃疡性结肠炎的临床研究进展  

Clinical research progress of Qingdaisan enema for ulcerative colitis treatment

作　　者：谢智钦[1] 李弘夏[1] 杜立阳[1] 

机构地区：[1]中国医科大学附属第一医院中医科,辽宁沈阳110001

出　　处：《中国医药导报》2013年第21期31-33,共3页China Medical Herald

基　　金：辽宁省自然科学基金课题(编号20092130)

摘　　要：目前溃疡性结肠炎的病因和发病机制都未明确,西医对本病的治疗主要采用氨基水杨酸制剂、糖皮质激素以及免疫抑制剂等,疗效及预后不是十分的理想,且存在不同程度的副作用,而青黛散灌肠在治疗本病方面有一定优势:药物直达病所、起效快、有效率高且能达到局部与整体综合治疗,临床疗效显著。本文就青黛散治疗溃疡性结肠炎的临床研究做一简要综述。Etiology and pathogenesis of ulcerative colitis are not clear so far. Amino salicylic acid preparation, gluco- corticoid and immunosuppressants are always used for its western medicine treatment, but the curative effects and prognosis are not ideal and there are different degrees of side effects. Qingdaisan enema therapy has some advantages in the treatment of ulcerative colitis： drugs directly to focus, rapid onset, high effective rate and achieving comprehen- sive treatment both locally and overall. In this essay, clinical studies of Qingdalsan for ulcerative colitis are briefly re- viewed.

关 键 词：溃疡性结肠炎 青黛散 灌肠治疗 

分 类 号：R259.746.2[医药卫生—中西医结合]